InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,705.45
(
-1.86%
)
US TECH 100
19,412.80
(
-2.23%
)
Dow Jones
41,763.46
(
-0.90%
)
Brent Oil
74.14
(
0.17%
)
Bitcoin
69,441.37
(
-1.09%
)
Post# of 253503
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120650
Boards Moderated 13
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 95532

Monday, 05/10/2010 7:27:25 PM

Monday, May 10, 2010 7:27:25 PM

Post# of 253503
IDIX Major Shareholders

[Updated for today’s SEC filing by T Rowe Price.]


The percentages shown below are based on 78.9.M diluted shares, the
share count I use for valuation purposes (#msg-49785732); hence, these
percentages differ from the ones reported in SEC filings. 
 
                      Shares    Stake 
 Novartis           31,322,836  39.7% 
 T Rowe Price        8,101,442† 10.3% 
 JP Sommadossi (CEO) 4,226,000*  5.4% 
 BB/MPM Capital      3,321,534   4.2% 
 GlaxoSmithKline     2,474,527   3.1%

†Based on Form 13G filed 5/10/10.
*Includes all 2.2M options, whether or not vested.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up